What is the appropriate treatment for a male urinary tract infection presenting with hematuria, proteinuria, nitrite‑positive urine, and lower abdominal or pelvic pain?

Treatment of Male UTI with Hematuria, Proteinuria, Nitrite-Positive Urine, and Lower Abdominal Pain

This male patient requires treatment for a complicated UTI with empirical broad-spectrum antibiotics for 7-14 days, as UTIs in males are inherently complicated and require longer treatment than simple cystitis in women. 1

Classification and Initial Assessment

UTIs in males are automatically classified as complicated UTIs (cUTIs) regardless of other factors, according to the European Association of Urology 2024 guidelines. 1 This classification is critical because:

• Male gender itself is a complicating factor requiring different management than uncomplicated cystitis in women 1
• The microbial spectrum is broader with higher antimicrobial resistance rates (E. coli, Proteus, Klebsiella, Pseudomonas, Serratia, and Enterococcus species) 1
• Prostatitis must be considered and cannot always be excluded clinically 1

Obtain urine culture and susceptibility testing immediately before starting empirical therapy—this is mandatory for all male UTIs. 1

Empirical Antibiotic Selection

For Outpatient Management (Mild-Moderate Illness)

If local fluoroquinolone resistance is <10%, use oral ciprofloxacin 500-750 mg twice daily for 7-14 days (14 days if prostatitis cannot be excluded). 1

If fluoroquinolone resistance is ≥10% or the patient has used fluoroquinolones in the last 6 months, avoid fluoroquinolones entirely. 1 Instead, consider:

• Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days (if local resistance <20%) 1
• Oral cephalosporins (cefpodoxime 200 mg twice daily or ceftibuten 400 mg daily for 10 days) with an initial IV dose of ceftriaxone 1

For Hospitalized Patients or Severe Illness

Start IV therapy with one of the following based on local resistance patterns: 1

• Ceftriaxone 1-2 g daily (preferred first-line for most cases) 1
• Ciprofloxacin 400 mg twice daily IV 1
• Levofloxacin 750 mg daily IV 1
• Aminoglycoside (gentamicin 5 mg/kg daily or amikacin 15 mg/kg daily) with or without ampicillin 1
• Piperacillin-tazobactam 2.5-4.5 g three times daily 1

Reserve carbapenems and novel broad-spectrum agents only for patients with early culture results showing multidrug-resistant organisms. 1

Treatment Duration

Treat for 7-14 days, with 14 days recommended when prostatitis cannot be excluded. 1 The European Association of Urology guidelines specifically state that men require 14 days when prostatitis is a consideration. 1

Shorter 7-day courses may be considered only if: 1

• The patient is hemodynamically stable
• Afebrile for at least 48 hours
• No evidence of prostatic involvement
• Relative contraindications exist to prolonged antibiotic use

Critical Diagnostic Considerations

The presence of nitrites on dipstick is highly specific for bacterial infection (more so than leukocyte esterase), supporting the diagnosis of true UTI rather than asymptomatic bacteriuria. 2, 3

Obtain upper urinary tract imaging (ultrasound initially) to rule out: 1

• Urinary tract obstruction
• Renal stone disease (especially given hematuria)
• Prostatic hypertrophy

If the patient remains febrile after 72 hours of appropriate therapy or clinically deteriorates, obtain contrast-enhanced CT immediately to evaluate for complications such as abscess, emphysematous pyelonephritis, or obstructive uropathy. 1

Common Pitfalls to Avoid

Do not treat this as simple cystitis with 3-5 day courses—single-dose or short-course therapy is inadequate in men and leads to treatment failure. 4

Do not use nitrofurantoin, fosfomycin, or pivmecillinam for empirical treatment—these agents have insufficient data for efficacy in complicated UTIs and upper tract infections. 1

Do not assume negative nitrites rule out infection—while nitrites are specific when positive, false negatives occur with dietary factors, dilute urine, or non-nitrate-reducing organisms. 5, 3

Avoid fluoroquinolones if the patient is from a urology department or has used them in the past 6 months due to high resistance rates in these populations. 1

Tailoring Therapy

Once culture and susceptibility results return (typically 48-72 hours), narrow therapy to the most appropriate agent based on identified organism and sensitivities. 1 This antimicrobial stewardship approach reduces collateral damage and resistance development. 6

Address any underlying urological abnormality—appropriate management of complicating factors (prostatic hypertrophy, stones, obstruction) is mandatory for successful treatment. 1